Perspectives on immunotherapy for hepatocellular carcinoma

被引：3

作者：

Schmidt, N. ^{[1
]}

Buettner, N. ^{[1
]}

Thimme, R. ^{[1
]}

机构：

[1] Univ Freiburg Klinikum, Abt Innere Med 2, D-79106 Freiburg, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2013年 / 138卷 / 14期

关键词：

hepatocellular carcinoma; immunotherapy; tumor immunology; T-CELL RESPONSES; ADOPTIVE IMMUNOTHERAPY; CANCER; RECURRENCE; PHENOTYPES; ANTIBODY; MELANOMA; SAFETY;

D O I：

10.1055/s-0032-1333030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：740 / 743

页数：4

共 22 条

[1] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[2] Potential of immunotherapy for hepatocellular carcinoma [J].

Breous, Ekaterina ;

Thimme, Robert .

JOURNAL OF HEPATOLOGY, 2011, 54 (04) :830-834

[3] Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer [J].

Butterfield, Lisa H. ;

Ribas, Antoni ;

Potter, Douglas M. ;

Economou, James S. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (12) :1931-1943

[4] IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J].

COX, AL ;

SKIPPER, J ;

CHEN, Y ;

HENDERSON, RA ;

DARROW, TL ;

SHABANOWITZ, J ;

ENGELHARD, VH ;

HUNT, DF ;

SLINGLUFF, CL .

SCIENCE, 1994, 264 (5159) :716-719

[5] Hepatocellular Carcinoma - from Immunobiology to Immunotherapy [J].

Flecken, T. ;

Schmidt, N. ;

Spangenberg, H. C. ;

Thimme, R. .

ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (01) :47-56

[6] Mechanisms and functional significance of tumour-induced dendritic-cell defects [J].

Gabrilovich, D .

NATURE REVIEWS IMMUNOLOGY, 2004, 4 (12) :941-952

[7] Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC [J].

Greten, Tim F. ;

Ormandy, Lars A. ;

Fikuart, Annika ;

Hoechst, Bastian ;

Henschen, Sylvana ;

Hoerning, Monique ;

Manns, Michael P. ;

Korangy, Firouzeh .

JOURNAL OF IMMUNOTHERAPY, 2010, 33 (02) :211-218

[8] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[9] Natural selection of tumor variants in the generation of "tumor escape" phenotypes [J].

Khong, HT ;

Restifo, NP .

NATURE IMMUNOLOGY, 2002, 3 (11) :999-1005

[10] Cancer immunotherapy comes of age [J].

Mellman, Ira ;

Coukos, George ;

Dranoff, Glenn .

NATURE, 2011, 480 (7378) :480-489

← 1 2 3 →